Jeffrey joined BroadBranch Advisors as an Associate in May 2026. Prior to joining BroadBranch, Jeffrey conducted postdoctoral research on Legionnaires’ disease at Johns Hopkins University and taught introductory chemistry laboratory at Towson University. Jeffrey has over 10 years of life science laboratory research experience in biochemistry, molecular biology, immunology, and virology. He completed his doctoral training at Vanderbilt University, studying DNA topology, and human and bacterial type II topoisomerases. He transitioned to life science strategy consulting to leverage his understanding of bioprocessing, pharma, and health systems to translate complex scientific findings to actionable market drivers and competitive intelligence.